EUDA Health Holdings Debt to Equity Ratio 2022-2025 | EUDA
Current and historical debt to equity ratio values for EUDA Health Holdings (EUDA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. EUDA Health Holdings debt/equity for the three months ending June 30, 2025 was 0.00.
| EUDA Health Holdings Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-06-30 | $0.01B | $0.00B | -1.57 |
| 2023-12-31 | $0.00B | 0.00 | |
| 2023-03-31 | $0.03B | $-0.01B | -5.29 |
| 2022-12-31 | $0.00B | 0.00 | |
| 2022-03-31 | $0.00B | $0.00B | 0.00 |
| 2021-12-31 | $0.01B | $0.00B | 12.33 |
| 2021-10-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.103B | $0.004B |
| EUDA Health Limited is a health technology company which operates southeast Asian digital healthcare ecosystem. The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions and aftercare services. EUDA Health Limited, formerly known as 8i Acquisition 2 Corp., is based in Singapore. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.404B | 55.40 |
| Tempus AI (TEM) | United States | $11.811B | 0.00 |
| Doximity (DOCS) | United States | $8.862B | 36.49 |
| Hims & Hers Health (HIMS) | United States | $8.100B | 65.89 |
| IRhythm Technologies (IRTC) | United States | $5.397B | 0.00 |
| Hinge Health (HNGE) | United States | $3.215B | 0.00 |
| Privia Health (PRVA) | United States | $2.856B | 178.62 |
| Inspire Medical Systems (INSP) | United States | $2.466B | 40.80 |
| Heartflow (HTFL) | United States | $2.248B | 0.00 |
| 10x Genomics (TXG) | United States | $1.987B | 0.00 |
| Enovis (ENOV) | United States | $1.618B | 8.50 |
| Omnicell (OMCL) | United States | $1.534B | 31.37 |
| Azenta (AZTA) | United States | $1.346B | 58.74 |
| Schrodinger (SDGR) | United States | $1.286B | 0.00 |
| Phreesia (PHR) | United States | $1.234B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.214B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.891B | 0.00 |
| Claritev (CTEV) | United States | $0.630B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 106.00 |
| Veradigm (MDRX) | United States | $0.517B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.498B | 0.00 |
| Standard BioTools (LAB) | United States | $0.465B | 0.00 |
| Evolent Health (EVH) | United States | $0.432B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| Carlsmed (CARL) | United States | $0.327B | 0.00 |
| TruBridge (TBRG) | United States | $0.308B | 14.15 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.274B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.256B | 0.00 |
| CapsoVision (CV) | United States | $0.248B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.208B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.192B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.162B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.158B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.152B | 0.00 |
| CareCloud (CCLD) | United States | $0.132B | 7.23 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| Pulmonx (LUNG) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.043B | 0.00 |
| Precipio (PRPO) | United States | $0.037B | 0.00 |
| 111 (YI) | China | $0.034B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |